Faecal Microbiota Transplantation
Cross-source consensus on Faecal Microbiota Transplantation from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Dosage & preparation
Evidence quality
Highlighted claims
- Faecal microbiota transplantation transfers stool from a healthy donor to restore a disrupted microbiome. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- TURN2 uses four weekly FMT administrations during weeks 0–3. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- The original TURN trial did not find a statistically significant remission difference between fresh nasoduodenal donor FMT and autologous FMT. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- Prior randomized trials of FMT for active ulcerative colitis reported treatment effects of 24–32% compared with placebo rates of 5–9%. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)
- Clinical response in the TURN trial correlated with recipients shifting toward the donor microbiota profile. — Transfer of faeces in ulcerative colitis 2: improving efficacy – study protocol for a multicentre randomised controlled trial (TURN2 study)